awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34854658-684C0BC8-1144-4AD8-B910-48717C169C22
Q34854658-684C0BC8-1144-4AD8-B910-48717C169C22
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34854658-684C0BC8-1144-4AD8-B910-48717C169C22
Antiangiogenic agents in combination with chemotherapy in patients with advanced non-small cell lung cancer.
P2860
Q34854658-684C0BC8-1144-4AD8-B910-48717C169C22
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34854658-684C0BC8-1144-4AD8-B910-48717C169C22
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4aeeac63813632015cdce2726b29ff24059434dd
P2860
FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.